1. Tianeptina: ¿por qué en España no ha sido catalogada como estupefaciente?;Calabozo;Rev Psiquiatr Salud Ment (Barc),2016
2. Haute Autorité de Santé (HAS). Comission de la transparence. Avis, 5 December 2012. Available at: http://www.has-sante.fr/portail/upload/docs/evamed/CT2029_STABLON_ReevalSMR_avis2_CT10411_CT12029.pdf [accessed 04.07.16].
3. Comité technique des Centres d’Evaluation et d’Information sur la Pharmacodépendance-CT022013043 Zolad,2014
4. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation;McEwen;Mol Psychiatry,2010
5. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study;Yoo;J Affect Disord,2015